Add like
Add dislike
Add to saved papers

First azole-resistant Aspergillus fumigatus isolates with the environmental TR 46 /Y121F/ T289A mutation in Iran.

Mycoses 2020 Februrary 14
BACKGROUND: Azole resistance in Aspergillus fumigatus is an emerging problem and reported from all continents. As triazole antifungals are the mainstay of therapy in the management of invasive aspergillosis, azole resistant A. fumigatus has become a major medical concern and with complicated clinical management.

OBJECTIVE: Screening of environmental presence of azole resistant A. fumigatus in Iran.

METHODS: Compost from Northern Iran, collected between 2017-2018, was screened for the presence of azole resistant A. fumigatus with azole-containing agar. Phenotypic MICs were obtained from selected, molecularly confirmed isolates. cyp51A gene sequencing and genotyping of azole resistant isolates was done.

RESULTS: Among 300 compost samples, three A fumigatus isolates had high voriconazole MICs (≥ 16 mg/L) and harbored the TR46 /Y121F/T289A mutation in the cyp51A gene. Microsatellite typing of these isolates showed that two strains had the same allele across all nine examined microsatellite loci and were genotypically related to Indian azole resistant strains. The other isolate had a different genotype.

CONCLUSION: This is the first report of A. fumigatus with TR46 /Y121F/T289A from the region. Monitoring and surveillance of antifungal susceptibility of clinical A. fumigatus is warranted in Iran and elsewhere in the region.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app